The recombinant proteins used to prepare therapeutics are obtained from recombinant organisms.
The production of recombinant therapeutics is possible only due to recombinant DNA technology.
Omgene recognized its commercial potential for manufacturing large volume peptides, so Omgene is planning to develop recombinant peptides like
Established in 2011, as a private limited company registered under Companies Act, 1956, we are quickly growing towards creating a vast impact on the healthcare industry.